Mesenchymal Stem-Cell-Derived Exosomes and MicroRNAs: Advancing Cell-Free Therapy in Systemic Sclerosis
Mesenchymal stem cell (MSC) transplantation has emerged as a potential therapeutic strategy for systemic sclerosis (SSc), a rare autoimmune disease characterized by inflammation, fibrosis, and vasculopathy. Recent evidence suggests that the therapeutic benefits of MSCs do not depend directly on thei...
Saved in:
| Main Authors: | Cristiano Barbetta, Francesco Bonomi, Gemma Lepri, Daniel E. Furst, Silvia Bellando Randone, Serena Guiducci |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/13/1018 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Translating Exosomal microRNAs from Bench to Bedside in Parkinson’s Disease
by: Oscar Arias-Carrión, et al.
Published: (2025-07-01) -
The role of MicroRNAs in mesenchymal stem cell differentiation into vascular smooth muscle cells
by: Sakhavat Abolhasani, et al.
Published: (2025-03-01) -
Exosomes and microRNAs as mediators of the exercise
by: Haoyuan Li, et al.
Published: (2025-01-01) -
Involvement of icaritin in the regulation of osteocyte exosomal microRNAs
by: Kaijia Zhang, et al.
Published: (2025-02-01) -
Highly Sensitive and Specific Panels of Plasma Exosomal microRNAs for Identification of Malignant Pulmonary Nodules
by: Rui Tao, et al.
Published: (2024-11-01)